CaviCide HP surface disinfectant offers a 1-minute universal contact time against 70 listed pathogens, utilizing a hydrogen peroxide formulation that meets all levels of the EPA’s rigorous Emerging Viral Pathogen Claim (EPA List Q)*, including enveloped viruses, small non-enveloped viruses, and large non-enveloped viruses. The High-Performance disinfection protocol of CaviCide HP ready-to-use disinfectant helps protect both patients and staff.
Features & Benefits
1-Step cleaning/disinfection** and 1-minute universal contact time for all listed pathogens ensures efficient disinfection.
Effective disinfection against 70 pathogens including MDRO’s (Multidrug Resistant Organisms) while qualifying for the EPA's rigorous Emerging Viral Pathogen claim against all virus tiers (enveloped, small and large non-enveloped) protecting you against future pathogens as well.
Pre-saturated wipes and ready-to-use liquids require no mixing or dilution simplifying the disinfection process, reducing the risk of errors, saving time, and improving compliance.
US EPA Toxicity Category IV products minimize exposure to harmful cleaning chemicals.
The use of gloves is not required.**
Kill Claims
Mycobacterium
Mycobacterium tuberculosis var: bovis (BCG)
Viruses (Non-Enveloped)
Human Norovirus
Human Rotavirus
Rhinovirus Type 37
Rhinovirus Type 1A
Human Adenovirus Type 5
Enterovirus Type D68
Viruses (Enveloped)
Herpes simplex virus Type 1 & Type 2
Avian Influenza A virus (H7N9)
Avian Influenza A virus (H5N1)
Influenza A virus (H3N2)
Influenza B virus (H1N1)
Parainfluenza virus Type 3
Hepatitis B virus (HBV)
Human Hepatitis C virus (HCV)
Human lmmunodeficiency virus Type 1 (HIV-1)